Halozyme Therapeutics, Inc.
HALO
$107.39
-$0.92-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.50% | 123.09% | -79.65% | 28.05% | -26.71% |
| Total Receivables | -0.47% | 3.79% | 27.52% | 9.39% | 3.85% |
| Inventory | -11.79% | -11.90% | -5.02% | 2.36% | 10.09% |
| Prepaid Expenses | 53.43% | 9.16% | -31.93% | 23.88% | 71.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 100.00% | -- | -- | -- | -- |
| Total Current Assets | -6.98% | 21.55% | -37.90% | 18.36% | -11.04% |
|
|
|||||
| Total Current Assets | -6.98% | 21.55% | -37.90% | 18.36% | -11.04% |
| Net Property, Plant & Equipment | 2.48% | 0.11% | 15.01% | -0.14% | -1.78% |
| Long-term Investments | -0.10% | 0.34% | 39.23% | 0.00% | 0.00% |
| Goodwill | -0.10% | 0.34% | 39.23% | 0.00% | 0.00% |
| Total Other Intangibles | -3.10% | -3.01% | 181.59% | -4.85% | -4.62% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.20% | -5.30% | 0.82% | -27.27% | 25.95% |
| Total Assets | -3.57% | 5.84% | 13.69% | 8.15% | -6.49% |
|
|
|||||
| Total Accounts Payable | 67.46% | -32.54% | 36.06% | -17.82% | -6.89% |
| Total Accrued Expenses | -20.31% | -3.14% | 30.34% | -3.81% | -11.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.11% | 1,751.05% | -98.41% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -5.17% | 105.10% | -78.85% | 523.48% | -10.70% |
|
|
|||||
| Total Current Liabilities | -5.17% | 105.10% | -78.85% | 523.48% | -10.70% |
| Long-Term Debt | 0.09% | -9.65% | 167.80% | -46.98% | 0.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.66% | 39.18% | -17.11% | -3.00% | -1.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.40% | -8.94% | 157.14% | 6.39% | 80.42% |
| Total Liabilities | -0.78% | -0.95% | 44.21% | -0.22% | 0.40% |
|
|
|||||
| Common Stock & APIC | -99.59% | 126.93% | -49.56% | 20,261.86% | -98.47% |
| Retained Earnings | -26.16% | 273.88% | -89.09% | 39.09% | -24.46% |
| Treasury Stock & Other | 38.36% | 29.79% | 18.72% | 21.64% | -732.20% |
| Total Common Equity | -34.65% | 349.94% | -90.31% | 51.44% | -31.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.65% | 349.94% | -90.31% | 51.44% | -31.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.65% | 349.94% | -90.31% | 51.44% | -31.00% |
|
|
|||||